Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

H. Lundbeck A/S663 enrolled

Overview

A study to evaluate the safety and effectiveness of Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia for insomnia (a sleep disorder).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

663

Conditions

Insomnia

Interventions

gaboxadolDRUG

Duration of Treatment -1 day

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy adults who are between the ages of 18 and 64 Exclusion Criteria: * Adults who are diagnosed with insomnia

Outcomes

Primary Outcomes

Amount of time spent awake and time to fall asleep during one night

Time frame: one night

Secondary Outcomes

Amount of deep sleep during one night.

Time frame: one night

Patient-reported sleep quality and awakenings during 1 night.

Time frame: one night

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.